RBC Cautious on Phreesia Inc. (PHR): 'we will be listening for further color on any potential for improved visibility into pharma marketing spending'

March 31, 2026 5:41 AM

RBC Capital analyst Sean Dodge reiterated an Outperform rating and $26.00 price target on Phreesia Inc. (NYSE: PHR).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found